Approval · Notice of Compliance 29337 · 2022
ZONTIVITY: Notice of Compliance 29337
Issued October 28, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29337
- Date
- October 28, 2022
- Company
- Xspire Pharma, LlcBrandon, Mississippi, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZONTIVITY | 02454815 | Cancelled Pre Market |
Medicinal ingredients
- VORAPAXAR SULFATE 2.5 MG per TAB